Stramsen Biotech Inc. Announced Military Veteran Mr. Chris White -(MBA) as The New President and Chief Financial Officer
HOUSTON, Aug. 29, 2023 /PRNewswire/ -- The Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced 32 Drug candidates in company's pipeline at a company's board meeting. These are new natural plant-based medicine candidates that are in different stages. The company's Board Members' meeting took place on July 30, 2023.
- HOUSTON, Aug. 29, 2023 /PRNewswire/ -- The Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced 32 Drug candidates in company's pipeline at a company's board meeting.
- Military Veteran Mr. Chris White –(MBA) has been appointed as The New President and Chief Financial Officer of Stramsen Biotech Inc. a Houston, Texas based biotech company.
- US Military Veteran Mr. Chris White holds a Master of Business Administration specializing in Global Business Management.
- Later, Chris became the Vice President of Operations for an emerging startup organization, Adaptive Construction Solutions, specializing in technical trade certified apprenticeship programs.